Cite
OC-0508 Molecular classification of endometrial cancer is predictive of response to adjuvant radiotherapy.
MLA
Horeweg, N., et al. “OC-0508 Molecular Classification of Endometrial Cancer Is Predictive of Response to Adjuvant Radiotherapy.” Radiotherapy & Oncology, vol. 182, May 2023, pp. S415–17. EBSCOhost, https://doi.org/10.1016/S0167-8140(23)08640-1.
APA
Horeweg, N., Nout, R. A., Jobsen, J. J., Lutgens, J. C., Jürgenliemk-Schulz, I. M., Haverkort, D. M., Mens, J. W. M., de Jong, M. A., Wortman, B. G., de Boer, S. M., Putter, H., Stelloo, E., Smit, V. T., Bosse, T., & Creutzberg, C. L. (2023). OC-0508 Molecular classification of endometrial cancer is predictive of response to adjuvant radiotherapy. Radiotherapy & Oncology, 182, S415–S417. https://doi.org/10.1016/S0167-8140(23)08640-1
Chicago
Horeweg, N., R.A. Nout, J.J. Jobsen, J.C. Lutgens, I.M. Jürgenliemk-Schulz, D.M. Haverkort, J.W.M. Mens, et al. 2023. “OC-0508 Molecular Classification of Endometrial Cancer Is Predictive of Response to Adjuvant Radiotherapy.” Radiotherapy & Oncology 182 (May): S415–17. doi:10.1016/S0167-8140(23)08640-1.